MedPath
NMPA Approval

Rituximab Injection

国药准字S20201002

April 15, 2020

国药准字S20190021

Drug Information

利妥昔单抗注射液

汉利康

注射剂

500mg/50ml/瓶

生物制品

April 15, 2020

Company Information

Applicant Company

上海市徐汇区宜山路1289号1幢(D楼)全幢

Manufacturing Company

上海市徐汇区宜山路1289号1幢(D楼)全幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利妥昔单抗注射液 - NMPA 批准文号 | MedPath